Key terms

About SGHT

Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest SGHT news

Yesterday 9:23am ET Sight Sciences price target raised to $6 from $5 at Piper Sandler by TipRanks Yesterday 8:18am ET Piper Sandler Sticks to Their Hold Rating for Sight Sciences (SGHT) by TipRanks Yesterday 5:17am ET Needham Remains a Hold on Sight Sciences (SGHT) by TipRanks May 02 4:48pm ET Sight Sciences backs FY24 revenue view $81M-$85M,consensus $82.48M by TipRanks May 02 4:46pm ET Sight Sciences reports Q1 EPS (33c), consensus (28c) by TipRanks May 02 4:25pm ET Sight Sciences Enhances Transparency with Strategic Financial Moves by TipRanks Apr 29 8:29am ET Sight Sciences announces $34M patent infringement verdict against Alcon by TipRanks Apr 10 4:19pm ET Sight Sciences publishes results from MIGS study in AJO by TipRanks Apr 02 5:53pm ET Sight Sciences to present GEMINI trial data at ASCRS by TipRanks Mar 08 7:47am ET Sight Sciences (SGHT) Receives a Hold from Piper Sandler by TipRanks Mar 08 5:41am ET Analysts Conflicted on These Healthcare Names: RAPT Therapeutics (RAPT), Eli Lilly & Co (LLY) and Sight Sciences (SGHT) by TipRanks Mar 08 5:40am ET Needham Remains a Hold on Sight Sciences (SGHT) by TipRanks Mar 07 4:35pm ET Sight Sciences Releases New Investor Relations Presentation by TipRanks Mar 07 4:33pm ET Sight Sciences reports Q4 EPS (22c), consensus (32c) by TipRanks Feb 16 7:30am ET Analysts Offer Insights on Healthcare Companies: Sight Sciences (SGHT), Integer Holdings (ITGR) and Pacific Biosciences (PACB) by TipRanks Feb 14 4:50pm ET Sight Sciences launches Ergo-Series of OMNI Surgical System in Europe by TipRanks

No recent press releases are available for SGHT

SGHT Financials

1-year income & revenue

Key terms

SGHT Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

SGHT Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Warren Buffett (L), CEO of Berkshire Hathaway, and Vice Chairman Charlie Munger attend the 2019 annual shareholders meeting in Omaha, Nebraska, May 3, 2019.
Johannes Eisele/AFP/Getty Images
Warren Buffett holds first Berkshire Hathaway meeting without Charlie Munger
People walk by the New York Stock Exchange (NYSE) on March 20, 2024 in New York City. The Dow was up slightly in late morning trading as traders analyze the Federal Reserve's latest decision on interest rates.
Spencer Platt/Getty Images
Stocks close higher after softer-than-expected jobs report fuels hopes of an earlier rate cut
People work at a Starbucks in Manhattan on February 02, 2024 in New York City.
Spencer Platt/Getty Images
Restaurants are competing for frugal diners’ dollars
Traders work on the floor of the New York Stock Exchange during afternoon trading on April 09, 2024 in New York City.
Michael M. Santiago/Getty Images/File
Sell in May and go away? Think again